Kiniksa Pharmaceuticals Ltd Earnings

The next earnings date for Kiniksa Pharmaceuticals Ltd is May 5, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Kiniksa Pharmaceuticals Ltd Earnings

Report Date	Estimated Earnings Per Share
05/05/2026	$0.32

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Kiniksa Pharmaceuticals Ltd Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
03/03/2026	---	$0.17	-51.01%
11/04/2025	---	$0.23	-26.73%
07/29/2025	---	$0.23	21.31%
06/05/2025	Before Market	$0.11	-61.17%
02/25/2025	---	$-0.12	-192.31%
10/29/2024	---	$-0.18	-366.67%
07/23/2024	Before Market	$-0.06	14.29%
04/23/2024	Before Market	$-0.25	-56.25%
02/28/2024	Before Market	$0.35	350.00%
10/31/2023	Before Market	$-0.20	-17.65%
07/25/2023	Before Market	$0.21	223.53%
05/02/2023	Before Market	$-0.18	14.29%
02/28/2023	Before Market	$0.06	126.09%
11/01/2022	Before Market	$3.18	307.69%
08/03/2022	Before Market	$-0.29	34.09%
05/03/2022	Before Market	$-0.36	12.20%
02/22/2022	Before Market	$-0.53	-26.19%
11/01/2021	Before Market	$-0.44	32.31%
08/03/2021	Before Market	$-0.61	22.78%
05/04/2021	Before Market	$-0.72	0.00%
02/23/2021	Before Market	$-0.79	-27.42%
11/05/2020	Before Market	$-0.66	-10.00%
07/30/2020	Before Market	$-0.65	-3.17%
04/28/2020	Before Market	$-0.48	23.81%
02/26/2020	Before Market	$-0.58	6.45%
10/28/2019	After Market	$-0.49	31.94%
08/12/2019	After Market	$-0.68	5.56%
05/02/2019	Before Market	$-1.27	-58.75%
03/07/2019	Before Market	$-0.88	-17.33%
11/01/2018	Before Market	$-0.51	5.56%
08/06/2018	Before Market	$-0.97	-120.45%
05/24/2018	After Market	$-0.10	---
03/07/2018	---	$0.02	---

More About Kiniksa Pharmaceuticals Ltd

Website

https://www.kiniksa.com

Country

USA

Full Time Employees

366

Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an investigational and fully human immunoglobulin G2 monoclonal antibody, which is Phase 2/3 clinical trial for the treatment of recurrent pericarditis; and KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody, which is in pre-clinical stage. The company was formerly known as Kiniksa Pharmaceuticals, Ltd. and changed its name to Kiniksa Pharmaceuticals International, plc in June 2024. Kiniksa Pharmaceuticals International, plc was incorporated in 2015 and is based in London, the United Kingdom.

“Kiniksa Pharmaceuticals Ltd Earnings” Can Refer to the Kiniksa Pharmaceuticals Ltd Earnings Date

Some people say “Kiniksa Pharmaceuticals Ltd earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Kiniksa Pharmaceuticals Ltd position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Kiniksa Pharmaceuticals Ltd Stock on the Earnings Date

If you own Kiniksa Pharmaceuticals Ltd stock (KNSA) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Kiniksa Pharmaceuticals Ltd might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Kiniksa Pharmaceuticals Ltd shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Kiniksa Pharmaceuticals Ltd Earnings

You can contact us any time if you would like to ask questions about Kiniksa Pharmaceuticals Ltd earnings or anything else related to the stock market.